Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

HINGHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer and distributer of the innovative LIBERTY ® Endovascular Robotic System, has partnered with a U.S. based third ...

HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY ® Endovascular Robotic System, announces that its Chief ...

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 1.54M 30 Jun 2025 2.30% 3,441,333 VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 474.6k 30 Jun 2025 0.71% 1,058,362 Fidelity ...

Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund 45.53k 31 Aug 2025 0.07% 125,657 Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund 32.18k 31 Aug 2025 0.05% ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.